ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 166 filers reported holding ANI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 6.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $488,000 | -32.9% | 14,882 | -28.2% | 0.00% | -66.7% |
Q2 2021 | $727,000 | +53.1% | 20,732 | +57.6% | 0.00% | 0.0% |
Q1 2021 | $475,000 | +114.9% | 13,152 | +92.2% | 0.00% | -25.0% |
Q2 2020 | $221,000 | -77.3% | 6,842 | -56.7% | 0.00% | -33.3% |
Q4 2019 | $975,000 | -31.7% | 15,810 | -9.0% | 0.01% | -57.1% |
Q2 2019 | $1,428,000 | +136.8% | 17,372 | +103.4% | 0.01% | +133.3% |
Q1 2019 | $603,000 | -8.1% | 8,542 | -41.4% | 0.01% | -25.0% |
Q4 2018 | $656,000 | +196.8% | 14,572 | +283.9% | 0.01% | +100.0% |
Q1 2018 | $221,000 | -83.5% | 3,796 | -81.7% | 0.00% | -82.6% |
Q4 2017 | $1,337,000 | +369.1% | 20,750 | +240.3% | 0.02% | +283.3% |
Q2 2017 | $285,000 | +14.9% | 6,097 | +49.1% | 0.01% | -40.0% |
Q4 2016 | $248,000 | -4.2% | 4,088 | +4.7% | 0.01% | -41.2% |
Q3 2016 | $259,000 | -58.8% | 3,904 | -79.1% | 0.02% | -65.3% |
Q1 2016 | $628,000 | +27.1% | 18,645 | +70.4% | 0.05% | -9.3% |
Q4 2015 | $494,000 | – | 10,945 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |